Laurent, A., Miller, H. I., Najac, R. D., Albero, R., Cortes, J. R., Ma, C., Lin, W. W., Wang, A., Alonso, R. A., Quevedo, L., Soni, R., Ouerfelli, O., Rabadan, R., Benezra, R., Palomero, T. (2025). Inhibitor of DNA binding 2 (ID2) is epigenetically regulated during lymphomagenesis and constitutes a novel therapeutic target in mature T-cell lymphoma. Blood. https://doi.org/10.1182/blood-2025-54